Challenges and Outcomes of Thrombolytic Therapy in Acute Ischemic Stroke: The Iranian Perspective
| Author | Amir Khanmirzaei | en |
| Author | Gelareh Azarinoush | en |
| Author | Melika Akbarimehr | en |
| Author | Nina Farzan | en |
| Author | Ali Mousavi | en |
| Orcid | Amir Khanmirzaei [0000-0003-4949-0306] | en |
| Issued Date | 2025-01-31 | en |
| Abstract | Background: Acute ischemic stroke (AIS) is a leading cause of mortality and long-term disability worldwide. In Iran, AIS tends to occur nearly a decade earlier than in developed nations, presenting unique challenges. Intravenous recombinant tissue plasminogen activator (IV-rtPA) is an effective thrombolytic therapy for AIS, but various factors limit its utilization. Objectives: This study aimed to identify the barriers to the administration of IV-rtPA in AIS patients at Shahid Beheshti Hospital in Qom, Iran. Methods: A cross-sectional descriptive-analytical study was conducted on AIS patients admitted between November 2021 and September 2022. A total of 322 patients were screened, and 178 met the inclusion criteria. Data on demographic characteristics, stroke severity (NIHSS score), comorbidities, onset-to-door time, and reasons for not receiving IV-rtPA were analyzed using SPSS version 22. Results: Of the 178 patients, 87 (48.9%) received IV-rtPA, while 91 (51.1%) did not. The primary reasons for withholding thrombolysis were clinical improvement (37.4%), late hospital arrival beyond 4.5 hours (24.2%), lack of consent (20.9%), the physician's conservative approach (11%), and mild progression of stroke symptoms (6.6%). A significant correlation was found between NIHSS score and reasons for non-receipt of therapy (P < 0.001). Patients with a prior stroke history were more likely to experience delays due to a physician’s conservative approach (28.6% vs. 5.7%, P < 0.01). Barriers to thrombolysis were also associated with lower education levels and a lack of public awareness about stroke symptoms. Conclusions: Delayed hospital admission and lack of consent were the leading barriers to IV-rtPA administration. Public awareness campaigns emphasizing the urgency of recognizing stroke symptoms and seeking timely medical care are crucial to improving thrombolysis rates and reducing AIS-related disabilities in Iran. | en |
| DOI | https://doi.org/10.5812/ans-150667 | en |
| Keyword | Acute Ischemic Stroke | en |
| Keyword | Fibrinolytic Agents | en |
| Keyword | Recombinant Tissue Plasminogen Activator | en |
| Keyword | Intracranial Hemorrhage | en |
| Keyword | Challenges and Outcomes | en |
| Publisher | Brieflands | en |
| Title | Challenges and Outcomes of Thrombolytic Therapy in Acute Ischemic Stroke: The Iranian Perspective | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ans-12-1-150667-publish-pdf.pdf
- Size:
- 436.72 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF